In his book The Wall Street Self-Defense Manual, disgraced former Merrill Lynch (NYSE: MER) internet stock analyst Henry Blodget explained his downfall this way:
If missing the top had been my only mistake, I would have survived . . . I also made a more serious mistake, however, which was to write a lot of emotional unprofessional e-mails, especially during the heat of the crash. Later, amid the wreckage, when the press, public, and regulators began calling for blood, my emails did me in . . . I was accused by New York State Attorney General Elliot Spitzer of having made remarks in e-mails that were "inconsistent" with my research (popular translation: "privately trashing stocks he was public recommending"). Along with others, I agreed to pay a humongous fine and be barred from the industry.
Cue the ironic music: Blodget has since experienced a comeback of sorts a blogger and columnist for Slate.com. Now that Spitzer's career is over after a gigantic scandal and guess where he'll be writing a column? Yep: at Slate.com with old friend. Is Slate planning to sell tickets to its Christmas party? Perhaps they could auction them off to raise money for people who lost money in the NASDAQ bubble, or perhaps pay for counseling for former prostitutes, or both.
Last updated: February 09, 2010: 11:28 PM
Hot Stocks
DailyFinance Headlines
- Disney Reports Flat Earnings But Sees Conditions Improving
- Google's Bad Buzz: Microsoft, Yahoo Mock New Social Product
- Paulson Predicts U.S. Will Recover 'Every Penny' of Bank Bailout Cash
- The Dow's Jump Doesn't Mean All's Well in Europe
- Hermes Opens Store Just for Men
TheFlyOnTheWall.com Headlines
- Papa John's is the investment choice of the big three players, Barrons.com says
- Coca-Cola's should continue to offer investors sweet returns, Barrons.com says
- Jim Cramer's "Mad Money"
- Terreno Realty 8.75M share IPO priced at $20.00
- MGP Ingredients, Inc. reports Q2 EPS 28c vs. consensus of 19c
BioHealth Investor Headlines
- Cell Therapeutics Facing Tougher FDA (CTIC)
- New Restless Leg Syndrome Review for XenoPort (XNPT, GSK)
- AMAG Fights Back (AMAG)
- Human Genome Sciences… When Insiders Sell Stock (HGSI)
- 10-Bagger Hunt Heads Back to Repros (RPRX)
WalletPop Headlines
- Borders coupon for 33% off
- No seed shortage for gardeners this spring, despite reports to the contrary
- Deaths spark crib recall: CSPC says to stop using Generation 2 and ChildESIGNS cribs
- Survey says? Homeowners think real estate collapse is over
- Dave Ramsey's recession-themed pick-up lines
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Money
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Dow Jones Industrial Average
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
- Zhu Zhu Pets
- Small Business Checking Account
- Crib Recall


